FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Torii Pharmaceutical Co., Ltd. Stock AnalysisComprehensive stock analysis for Torii Pharmaceutical Co., Ltd. (TRXPF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTRXPF
TRXPF
Torii Pharmaceutical Co., Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TRXPF
Home🔹Stocks🔹Torii Pharmaceutical Co., Ltd.

Torii Pharmaceutical Co., Ltd.

TRXPF•OTC

Torii Pharmaceutical Co., Ltd.

TRXPF•OTC
Market cap
$690.70M
Sentiment

Your view on TRXPF

Mkt Cap
$690.70M
Sentiment
Your view
TRXPF
Torii Pharmaceutical Co., Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TRXPF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Torii Pharmaceutical Co., Ltd.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Goichi Matsuda
Headquarters
Torii Nihonbashi Bldg., Tokyo, JP
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Goichi Matsuda
Headquarters
Torii Nihonbashi Bldg., Tokyo, JP
Description

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News